Shield Therapeutics PLC logo

Shield Therapeutics PLC

NEW
LSE:STX (UK)  
£ 0.056 -0.0025 (-4.31%) Sep 3
At Loss
Market Cap:
£ 59.38M ($ 80.13M)
Enterprise V:
£ 73.96M ($ 99.81M)
Volume:
1.40M
Avg Vol (2M):
3.15M
Trade In:
Volume:
1.40M
At Loss

Shield Therapeutics PLC (LSE:STX) Dividend

Shield Therapeutics PLC (LSE:STX) does not currently pay a regular dividend. Over the past 3 years it has returned capital to shareholders via buybacks at a rate of -60.3%. View its historical dividend record below and compare with dividend-paying peers.

Frequently Asked Questions: LSE:STX Dividend

Does Shield Therapeutics PLC (LSE:STX) pay a dividend?

Shield Therapeutics PLC (LSE:STX) does not currently pay a regular dividend. Review the historical record above for any past dividend payments or capital return policies.

Why doesn't Shield Therapeutics PLC pay a dividend?

Companies typically forgo dividends to reinvest earnings into growth, R&D, acquisitions, or share buybacks. Shield Therapeutics PLC has returned capital to shareholders via buybacks at a rate of -60.3% over the past 3 years.

What are dividend-paying alternatives to Shield Therapeutics PLC?

For dividend-paying alternatives in Shield Therapeutics PLC's sector, view dividend stocks by industry on GuruFocus's dividend stock screener.